Lisa Delfini
Director of Finance/CFO bei TREVI THERAPEUTICS, INC.
Vermögen: 123 858 $ am 31.03.2024
Ursprung des Netzwerks ersten Grades von Lisa Delfini
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Public Company | Biotechnology | 15 | |
Marcum LLP
Marcum LLP Miscellaneous Commercial ServicesCommercial Services Marcum LLP operates as a public accounting and advisory services firm. It offers bankruptcy and insolvency; cost segregation; financial statements; personal financial management; tax advisory; tax controversy resolution; and tax-exempt business services. The company was founded by Edwin J. Kliegman and Edwin Marcum in 1951 and is headquartered in New York, NY.
5
| Subsidiary | Miscellaneous Commercial Services | 5 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Lisa Delfini
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
KERYX BIOPHARMACEUTICALS | Pharmaceuticals: Major | Director/Board Member | |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Chief Executive Officer | |
SANOFI | Miscellaneous Commercial Services | Corporate Officer/Principal | |
TYRX, Inc.
TYRX, Inc. Electronic Equipment/InstrumentsElectronic Technology TYRX, Inc. designs and manufactures medical-pharmaceutical combination devices. The firm commercializes implantable combination drug and device products focused on infection control including the AIGISRx Antibacterial Envelope, designed to reduce surgical site infections associated with cardiac implantable electronic devices (CIEDs). Its AIGISRx products contain the antimicrobial agents, rifampin and minocycline, which have been shown to reduce infection by pathogens responsible for the majority of CIED infections, including superbugs such as methicillin-resistant S. aureus (MRSA). The company was founded in 1998 by Satish Pulapura and Arikha Moses and is headquartered in Monmouth Junction, NJ. | Electronic Equipment/Instruments | Director/Board Member | |
COLLEGIUM PHARMACEUTICAL, INC. | Pharmaceuticals: Major | Founder | |
VELOXIS PHARMACEUTICALS A/S | Pharmaceuticals: Major | Chairman | |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
NormOxys, Inc.
NormOxys, Inc. Pharmaceuticals: MajorHealth Technology NormOxys, Inc. develops small-molecule therapeutics for the treatment of cancer. Its major product is OXY111A. The company was founded by Conrad J Bletzer, Jr. Claude Nicoalu, Jean-Mearie Lehn, Gay Goodman, Ruth Greferath and Roscoe Brady in 2004 and is headquartered in Brighton, MA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
MYOKARDIA, INC. | Pharmaceuticals: Major | Director/Board Member | |
RHYTHM PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Director/Board Member Chief Executive Officer | |
Massachusetts Institute of Technology | College/University | Undergraduate Degree Doctorate Degree | |
The Ohio State University
The Ohio State University Other Consumer ServicesConsumer Services Global Factory, Inc. provides collaborative manufacturing execution systems. The firm's software gather, organize & analyze demand, production & quality data from various sources and monitor key indicators & execute business processes to control, manage & optimize distributed manufacturing operations. The company was founded in 1999 and is headquartered in Santa Clara, CA. | College/University | Corporate Officer/Principal | |
University of Connecticut | College/University | Undergraduate Degree | |
OCATA THERAPEUTICS INC | Pharmaceuticals: Major | Chairman | |
New England Healthcare Institute
New England Healthcare Institute Miscellaneous Commercial ServicesCommercial Services New England Healthcare Institute operates as a national nonprofit, nonpartisan organization composed of stakeholders from across all key sectors of health and health care. The company was founded by Henri A. Termeer in 2002 and is headquartered in Boston, MA. | Miscellaneous Commercial Services | Director/Board Member | |
AKEBIA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Genzyme Europe BV
Genzyme Europe BV Pharmaceuticals: MajorHealth Technology Part of Sanofi, Genzyme Europe BV is a Dutch company that develops and manufactures pharmaceutical and biotherapeutic products. The private company is based in Amsterdam, Netherlands. | Pharmaceuticals: Major | Corporate Officer/Principal | |
CORNERSTONE THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
The Cleveland Clinic Foundation
The Cleveland Clinic Foundation Medical/Nursing ServicesHealth Services The Cleveland Clinic Foundation operates as a non-profit academic, research, and medical center. It offers clinic and hospital care with research and education services. The company was founded by Charles Posternack, George W. Crile, Frank E. Bunts, William E. Lower and John Phillips on February,5 1921 and is headquartered in Cleveland, OH. | Medical/Nursing Services | Corporate Officer/Principal | |
SmithKline Beecham Ltd.
SmithKline Beecham Ltd. Pharmaceuticals: MajorHealth Technology Smithkline Beecham Ltd. manufacture of basic pharmaceutical products. It also provides mineral water, bottled water, and soft drinks. The company was founded on January 24, 1989 and is headquartered in Brentford, the United Kingdom. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Prize4Life, Inc.
Prize4Life, Inc. Miscellaneous Commercial ServicesCommercial Services Prize4Life, Inc. is a non-profit organization that aims to accelerate the discovery of treatments and a cure for ALS (Amyotrophic Lateral Sclerosis), also known as Lou Gehrig's disease. Prize4Life uses powerful incentives to attract new people and drive innovation in ALS research. The American company believes that out-of-the-box thinking is necessary to find solutions to the biggest challenges in ALS research, and that critical discoveries may come from unlikely places. Prize4Life encourages and rewards creative approaches that will yield real results for ALS patients. The non-profit company was founded by Guy Yamen and Nate Boaz in 2007. | Miscellaneous Commercial Services | Director/Board Member | |
Onset Dermatologics LLC
Onset Dermatologics LLC Pharmaceuticals: MajorHealth Technology Onset Dermatologics LLC develops and markets prescription product for skin disorders. The company was founded in 2005 and is headquartered in Cumberland, RI. | Pharmaceuticals: Major | Chief Executive Officer | |
OBSEVA SA | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | Pharmaceuticals: Major | Director/Board Member | |
WILSON THERAPEUTICS AB | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
University of Vermont College of Medicine | College/University | Doctorate Degree | |
PHARVARIS N.V. | Pharmaceuticals: Major | Chairman | |
NMD Pharma A/S
NMD Pharma A/S BiotechnologyHealth Technology NMD Pharma ApS engages with the research and preparation of small molecules targeting an undisclosed ion. It offers medical treatment of neuromuscular diseases for patients with chronic muscle wasting diseases such as myasthenia gravis and amyotrophic lateral sclerosis. The company was founded by Ole B?kgaard Nielsen, Thomas Holm Pedersen, and Claus Elsborg Olesen on May 7, 2015 and is headquartered in Aarhus, Denmark. | Biotechnology | Chairman | |
Indalo Therapeutics, Inc.
Indalo Therapeutics, Inc. BiotechnologyHealth Technology Indalo Therapeutics, Inc. operates as a biopharmaceutical firm that develops integrin antagonists for patients suffering from serious fibrotic diseases such as nonalcoholic steatohepatitis (NASH) and idiopathic pulmonary fibrosis (IPF). The company was founded by David Griggs, Williamson Z. Bradford III, Peter Ruminski, and Robert W. Karr and is headquartered in Cambridge, MA. | Biotechnology | Chairman | |
KSQ Therapeutics, Inc.
KSQ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology KSQ Therapeutics, Inc. develops and deploys precision functional genomics to discover therapies that transform patient lives. The company was founded by Tim Wang and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Chief Executive Officer | |
CTx Operations, Inc.
CTx Operations, Inc. BiotechnologyHealth Technology CTx Operations, Inc. operates as a pre-clinical stage biotechnology company. It develops novel cellular therapeutics. The company was founded by Saar Gill and Michael Klichinsky in 2017 and is headquartered in Philadelphia, PA. | Biotechnology | Chairman | |
SYNLOGIC, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Inversago Pharma, Inc.
Inversago Pharma, Inc. Pharmaceuticals: MajorHealth Technology Inversago Pharma, Inc. develops novel gastrointestinal drugs. The company was founded by Fran?ois Ravenelle in and is headquartered in Montreal, Canada. | Pharmaceuticals: Major | Director/Board Member | |
Avenge Bio, Inc.
Avenge Bio, Inc. Pharmaceuticals: MajorHealth Technology Avenge Bio, Inc. is an oncology-focused biotechnology company based in the United States. The American company develops cell-based immunotherapeutic products for the treatment of solid tumors using its proprietary Lococyte™ platform. The platform delivers engineered cells to the local tumor environment, generating high concentrations of immune effector molecules in proximity to the tumor, which initiates a robust, local, and durable systemic immune response while avoiding toxicities associated with systemic immunotherapies. Avenge's most advanced product candidate, AVB-001, produces native IL-2 immunotherapy and is initially being studied in metastatic peritoneal cancers such as ovarian cancer. The company has additional pipeline candidates for the treatment of a wide range of cancers, including pancreatic, lung, and breast cancers. Avenge was founded in 2019 by Paul Kevin Wotton and Michael Thomas Heffernan, with Heffernan serving as CEO since incorporation. | Pharmaceuticals: Major | Founder | |
TURMERIC ACQUISITION CORP. | Financial Conglomerates | Director/Board Member | |
Pharvaris GmbH
Pharvaris GmbH Pharmaceuticals: MajorHealth Technology Pharvaris GmbH operates as a clinical-stage company. It specializes in medicinal chemistry, drug discovery and development and hereditary angioedema. The company was founded by Berndt A. E. Modig, Jochen Knolle, Anne Lesage and Hans G. C. P. Schikan in October 2015 and is headquartered in Zug, Switzerland. | Pharmaceuticals: Major | Chairman | |
K36 Therapeutics, Inc.
K36 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology K36 Therapeutics, Inc. develops small molecule therapeutics. The company is based in Cambridge, MA. The company was founded in 2021. The CEO is Terry Connolly. | Pharmaceuticals: Major | Director/Board Member | |
Sorriso Pharmaceuticals, Inc.
Sorriso Pharmaceuticals, Inc. BiotechnologyHealth Technology Sorriso Pharmaceuticals, Inc. is an American biotechnology company that focuses on developing disease-modifying antibodies to treat inflammatory diseases. Sorriso Pharmaceuticals was founded by Ciara Kennedy, who has been the CEO since its incorporation. | Biotechnology | Director/Board Member | |
BIOHAVEN LTD. | Pharmaceuticals: Major | Director/Board Member | |
New Enterprise Associates, Inc. | Corporate Officer/Principal |
Statistik
International
Vereinigte Staaten | 38 |
Frankreich | 3 |
Dänemark | 3 |
Niederlande | 3 |
Schweiz | 3 |
Sektoral
Health Technology | 36 |
Commercial Services | 7 |
Consumer Services | 4 |
Health Services | 3 |
Finance | 3 |
Operativ
Director/Board Member | 106 |
Corporate Officer/Principal | 41 |
Independent Dir/Board Member | 41 |
President | 21 |
Chief Executive Officer | 19 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Ed Mathers Mathers | 47 |
Anne VanLent | 23 |
Michael Heffernan | 23 |
David J. Clark | 21 |
David Meeker | 19 |
William Forbes | 11 |
Kathy Raffa | 11 |
Jennifer Good | 10 |
Tracy Curley | 8 |
Dominick Colangelo | 8 |
Thomas Sciascia | 7 |
James Cassella | 7 |
Christopher Galletta | 5 |
Danine Summers | 5 |
Maury Cartine | 5 |
- Börse
- Insiders
- Lisa Delfini
- Unternehmensverbindungen